CM Management
Latest statistics and disclosures from CM Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ALCO, TGB, FOLD, RPRX, NMRK, and represent 21.72% of CM Management's stock portfolio.
- Added to shares of these 10 stocks: INCY, WBA, BIDU, JAZZ, BABA, INTT, CLPT, PLPC, RPRX, CRIS.
- Started 8 new stock positions in THFF, BABA, CGTX, VTOL, BIDU, VRNA, INCY, JAZZ.
- Reduced shares in these 10 stocks: , NHC, , , BGC, FNF, , APA, USAP, VTLE.
- Sold out of its positions in APA, NEUE, TAST, FIS, FNF, FCX, ImmunoGen, VTLE, NHC, Safeguard Scientifics. USAP.
- CM Management was a net seller of stock by $-6.1M.
- CM Management has $121M in assets under management (AUM), dropping by -4.83%.
- Central Index Key (CIK): 0001841857
Tip: Access up to 7 years of quarterly data
Positions held by CM Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for CM Management
CM Management holds 69 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ali (ALCO) | 5.2 | $6.3M | 215k | 29.28 |
|
|
| Taseko Cad (TGB) | 4.5 | $5.4M | 2.5M | 2.17 |
|
|
| Amicus Therapeutics (FOLD) | 4.4 | $5.3M | 450k | 11.78 |
|
|
| Royalty Pharma (RPRX) | 4.0 | $4.9M | +28% | 160k | 30.37 |
|
| Newmark Group Com - Class A (NMRK) | 3.7 | $4.4M | 400k | 11.09 |
|
|
| Arko Corp (ARKO) | 3.4 | $4.1M | +18% | 720k | 5.70 |
|
| Radiant Logistics (RLGT) | 3.2 | $3.9M | +5% | 725k | 5.42 |
|
| Iovance Biotherapeutics (IOVA) | 3.1 | $3.7M | 250k | 14.82 |
|
|
| American Superconductor (AMSC) | 2.8 | $3.4M | +28% | 250k | 13.51 |
|
| Preformed Line Products Company (PLPC) | 2.8 | $3.3M | +48% | 26k | 128.67 |
|
| Kyndryl Holdings Ord Wi (KD) | 2.5 | $3.0M | 140k | 21.76 |
|
|
| Walgreen Boots Alliance (WBA) | 2.5 | $3.0M | +115% | 140k | 21.69 |
|
| inTEST Corporation (INTT) | 2.5 | $3.0M | +87% | 225k | 13.25 |
|
| Rigel Pharmaceuticals (RIGL) | 2.4 | $3.0M | +17% | 2.0M | 1.48 |
|
| Pagerduty (PD) | 2.2 | $2.7M | 120k | 22.68 |
|
|
| Clearpoint Neuro (CLPT) | 2.1 | $2.6M | +87% | 375k | 6.80 |
|
| Ark Restaurants (ARKR) | 2.1 | $2.5M | 185k | 13.75 |
|
|
| Bgc Group Inc Cl A (BGC) | 2.1 | $2.5M | -43% | 325k | 7.77 |
|
| Coherus Biosciences (CHRS) | 2.0 | $2.4M | +21% | 1.0M | 2.39 |
|
| Viatris (VTRS) | 2.0 | $2.4M | 200k | 11.94 |
|
|
| Organon & Co (OGN) | 1.9 | $2.4M | 125k | 18.80 |
|
|
| Evolus (EOLS) | 1.7 | $2.1M | 150k | 14.00 |
|
|
| Service Pptys Tr Com Sh Ben Int (SVC) | 1.7 | $2.0M | +20% | 300k | 6.78 |
|
| Brookline Ban (BRKL) | 1.5 | $1.8M | 180k | 9.96 |
|
|
| Warner Bros. Discovery (WBD) | 1.4 | $1.7M | +60% | 200k | 8.73 |
|
| Talos Energy (TALO) | 1.4 | $1.7M | +78% | 125k | 13.93 |
|
| Incyte Corporation (INCY) | 1.4 | $1.7M | NEW | 30k | 56.97 |
|
| Baidu Sponsored Ads (BIDU) | 1.3 | $1.6M | NEW | 15k | 105.28 |
|
| First Horizon National Corporation (FHN) | 1.3 | $1.5M | +100% | 100k | 15.40 |
|
| Republic Bancorp Ky Com - Class A (RBCAA) | 1.3 | $1.5M | +9% | 30k | 51.00 |
|
| Pan American Silver Corp Can (PAAS) | 1.2 | $1.5M | 100k | 15.08 |
|
|
| Jazz Pharmaceuticals (JAZZ) | 1.2 | $1.5M | NEW | 13k | 120.42 |
|
| Centerra Gold (CGAU) | 1.2 | $1.5M | +66% | 250k | 5.91 |
|
| AMCON Distributing (DIT) | 1.2 | $1.5M | 8.0k | 184.00 |
|
|
| Alibaba Group Hldg Sponsored Ads (BABA) | 1.2 | $1.4M | NEW | 20k | 72.36 |
|
| Newell Rubbermaid (NWL) | 1.2 | $1.4M | 175k | 8.03 |
|
|
| Pfizer (PFE) | 1.1 | $1.4M | 50k | 27.75 |
|
|
| Barrick Gold Corp (GOLD) | 1.1 | $1.3M | +60% | 80k | 16.64 |
|
| Xoma Corp Del (XOMA) | 1.1 | $1.3M | 55k | 24.05 |
|
|
| Curis (CRIS) | 1.1 | $1.3M | +380% | 120k | 10.87 |
|
| Revance Therapeutics (RVNC) | 1.0 | $1.2M | +233% | 250k | 4.92 |
|
| Sabre (SABR) | 1.0 | $1.2M | +66% | 500k | 2.42 |
|
| Atea Pharmaceuticals (AVIR) | 0.9 | $1.1M | 270k | 4.04 |
|
|
| Coya Therapeutics (COYA) | 0.8 | $992k | 100k | 9.92 |
|
|
| Nektar Therapeutics (NKTR) | 0.7 | $878k | 940k | 0.93 |
|
|
| Park Hotels & Resorts Inc-wi (PK) | 0.7 | $875k | -16% | 50k | 17.49 |
|
| Heron Therapeutics (HRTX) | 0.7 | $831k | -7% | 300k | 2.77 |
|
| Cytosorbents (CTSO) | 0.6 | $784k | +98% | 825k | 0.95 |
|
| ACADIA Pharmaceuticals (ACAD) | 0.6 | $740k | +33% | 40k | 18.49 |
|
| Battalion Oil Corp (BATL) | 0.6 | $736k | +20% | 130k | 5.66 |
|
| Tejon Ranch Company (TRC) | 0.6 | $694k | +12% | 45k | 15.41 |
|
| Femasys (FEMY) | 0.5 | $620k | -11% | 400k | 1.55 |
|
| Compass Therapeutics (CMPX) | 0.5 | $614k | +148% | 310k | 1.98 |
|
| Lantern Pharma (LTRN) | 0.5 | $572k | -18% | 65k | 8.80 |
|
| Elicio Therapeutics (ELTX) | 0.5 | $570k | +50% | 75k | 7.60 |
|
| Verona Pharma Sponsored Ads (VRNA) | 0.5 | $563k | NEW | 35k | 16.09 |
|
| First Financial Corporation (THFF) | 0.4 | $537k | NEW | 14k | 38.33 |
|
| Bristow Group (VTOL) | 0.3 | $418k | NEW | 15k | 27.20 |
|
| Gain Therapeutics (GANX) | 0.3 | $339k | 90k | 3.77 |
|
|
| Assertio Holdings (ASRT) | 0.3 | $331k | 345k | 0.96 |
|
|
| Eledon Pharmaceuticals (ELDN) | 0.3 | $330k | +14% | 160k | 2.06 |
|
| Kronos Bio (KRON) | 0.3 | $325k | 250k | 1.30 |
|
|
| Cognition Therapeutics (CGTX) | 0.3 | $319k | NEW | 175k | 1.82 |
|
| Cadence Bank (CADE) | 0.2 | $290k | 10k | 29.00 |
|
|
| Biocardia (BCDA) | 0.2 | $285k | 700k | 0.41 |
|
|
| Edesa Biotech (EDSA) | 0.2 | $260k | 62k | 4.19 |
|
|
| smith Micro Software (SMSI) | 0.2 | $207k | 600k | 0.34 |
|
|
| Selecta Biosciences (RNAC) | 0.2 | $199k | -56% | 306k | 0.65 |
|
| Pieris Pharmaceuticals (PIRS) | 0.1 | $105k | -23% | 575k | 0.18 |
|
Past Filings by CM Management
SEC 13F filings are viewable for CM Management going back to 2020
- CM Management 2024 Q1 filed May 14, 2024
- CM Management 2023 Q4 filed Feb. 12, 2024
- CM Management 2023 Q3 filed Nov. 7, 2023
- CM Management 2023 Q2 filed Aug. 4, 2023
- CM Management 2023 Q1 filed May 8, 2023
- CM Management 2022 Q4 filed Feb. 9, 2023
- CM Management 2022 Q3 filed Nov. 4, 2022
- CM Management 2022 Q2 filed Aug. 8, 2022
- CM Management 2022 Q1 filed May 9, 2022
- CM Management 2021 Q4 filed Feb. 2, 2022
- CM Management 2021 Q3 filed Nov. 8, 2021
- CM Management 2021 Q2 filed Aug. 10, 2021
- CM Management 2021 Q1 filed May 12, 2021
- CM Management 2020 Q4 filed Feb. 4, 2021